See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2017_Regenerx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000707511, Regenerx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 849,431 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,219 |
| 3 | remainder_Assets | 5,752 |
| 4 | LiabilitiesCurrent | 659,756 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,269,204 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,541,072 |
| 9 | ResearchAndDevelopmentExpense | 226,118 |
| 10 | remainder_Expenses | 173,328 |
| 11 | remainder_Revenues | 129,845 |
| 12 | remainder_NetIncome | -9,437 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 862,402 |
| 1 | Liabilities | 6,928,960 |
| 2 | Expenses | 1,940,518 |
| 3 | Revenues | 129,845 |
| 4 | StockholdersEquity | -6,066,558 |
| 5 | NetIncome | -1,820,110 |
| 6 | ComprehensiveNetIncome | -1,820,110 |
| 7 | BaseVar | 4,935,581 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.86 |
| 9 | EconomicCapitalRatio | 0.428 |
Edgar->Model Mapping
Feature Distribution
Change over Time
